Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2007;115:3130-3138
doi: 10.1161/CIRCULATIONAHA.106.677591
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pollex, R. L.
Right arrow Articles by Hegele, R. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pollex, R. L.
Right arrow Articles by Hegele, R. A.
Related Collections
Right arrow Clinical genetics
Right arrow Functional genomics
Right arrow Genomics
Right arrow Genetics of cardiovascular disease

(Circulation. 2007;115:3130-3138.)
© 2007 American Heart Association, Inc.


Contemporary Reviews in Cardiovascular Medicine

Copy Number Variation in the Human Genome and Its Implications for Cardiovascular Disease

Rebecca L. Pollex, MSc; Robert A. Hegele, MD, FRCPC

From the Robarts Research Institute and University of Western Ontario, London, Ontario, Canada.

Correspondence to Robert A. Hegele, MD, FRCPC, Blackburn Cardiovascular Genetics Laboratory, Robarts Research Institute, 100 Perth Dr, Room 406, London, Ontario, Canada, N6A 5K8. E-mail hegele@robarts.ca


Key Words: DNA • genetics • genomics • myocardial infarction • risk factors • stroke


An extract of the first 250 words of the full text is provided, because this article has no abstract.
 


*    Introduction
 
Unlocking the information contained within the human genome will likely advance our understanding of cardiovascular (CV) health and disease by leading to discovery of new molecules, pathways, and networks. A central strategy in genetic studies of CV disease has been to correlate human genomic DNA variation with clinical phenotypes, such as myocardial infarction, heart failure, stroke, and their risk factors, with a range of experimental designs and analytical procedures. The ability to detect genomic differences between individuals is the foundation of this research. Human genomic variation exists in many forms, each of which has unique qualitative and quantitative features. Each form of human genomic variation is composed of many individual variants that occur across the genome. The population frequency of individual variants can range from rare to common. The effect of a specific genomic variant can range from beneficial to neutral to deleterious. To rapidly translate genomic knowledge into diagnosis and treatment of CV disease, it is logical to search for common genomic variants that have a non-neutral impact. In the recent past, one form of genomic variation, the single-nucleotide variant, has dominated the experimental landscape: It is the currency of present genetic CV disease studies. However, recent developments indicate that the focus on single-nucleotide polymorphisms (SNPs) alone will not capture the full range of meaningful human genomic variation, such as a newly characterized and annotated form called copy number variation (CNV).


*    Main Varieties of Human Genomic Variation
 
The main forms of human genomic variation are shown in Figure 1. These include SNPs, which are . . . [Full Text of this Article]




This article has been cited by other articles:


Home page
CirculationHome page
K. L. Lunetta
Genetic Association Studies
Circulation, July 1, 2008; 118(1): 96 - 101.
[Full Text] [PDF]


Home page
StrokeHome page
S.-M. Brand-Herrmann
Where Do We Go for Atherothrombotic Disease Genetics?
Stroke, April 1, 2008; 39(4): 1070 - 1075.
[Full Text] [PDF]


Home page
StrokeHome page
R. A. Hegele and M. Dichgans
Update on the Genetics of Stroke and Cerebrovascular Disease 2007
Stroke, February 1, 2008; 39(2): 252 - 254.
[Full Text] [PDF]


Home page
Am J EpidemiolHome page
L. Kuller
Is Phenomenology the Best Approach to Health Research?
Am. J. Epidemiol., November 15, 2007; 166(10): 1109 - 1115.
[Abstract] [Full Text] [PDF]